The Edo state-owned Ambrose Alli University, Ekpoma, said it has made a major breakthrough in its research and higher learning; following the approval of the institution’s rights of production and patents of GLUCOZIL.

The Sub-Dean, Basic Clinical Sciences, College of Medicine of the institution, Dr. Jonathan Emeka Emordi said the National Agency For Food And Drug Administration And Control (NAFDAC) had given approval for the product production and usage.

Emordi who is also the Head Department of Pharmacology, described GLUCOZIL as a natural product that is prepared for the treatment of diabetes mellitus.

According to him, “GLUCOZIL as a Natural Product is manufactured to cause a regeneration of the beta cells that have been destroyed. If the product is used for a very long period, it will not only manage diabetes but cure it completely”.

The DON also stated that GLUCOZIL which can be used for the management, treatment and cure of diabetes, has bonus clinical indications for the treatment of enlarged prostate.

He said: “in my analysis of the product, it was discovered that it has the capacity to shrink the prostate so that surgical operations can be avoided.

“The product is scientifically tested. Right dose confirmed, safety proven in both humans and animals. It is also capable of flushing the human system,” he said.

On his part, the Acting Vice Chancellor, Ambrose Alli University, Ekpoma, Prof. Asomwan Sonnie Adagbonyin said: “we are proud of the ranking of our scholars who are determined to excel, do us proud despite the various human and environmental challenges”.

Courtesy:BluePrint